share_log

BTIG Initiates Coverage On Abivax With Buy Rating, Announces Price Target of $43

Benzinga ·  May 20 07:36

BTIG analyst Julian Harrison initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $43.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment